{"doi":"10.4143/crt.2024.859","title":"Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem Cells","abstract":null,"journal":"Cancer Research and Treatment","year":2025,"id":624707,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":461181,"name":"Nicholas A. Graham","orcid":"0000-0002-6811-1941","position":1,"is_corresponding":false},{"id":1614999,"name":"Eduard H. Panosyan","orcid":null,"position":2,"is_corresponding":false},{"id":679561,"name":"Jack Mottahedeh","orcid":null,"position":3,"is_corresponding":false},{"id":404858,"name":"Eric R. Samuels","orcid":"0000-0001-7888-1870","position":4,"is_corresponding":false},{"id":1615002,"name":"Araceli Nunez","orcid":null,"position":5,"is_corresponding":false},{"id":1615003,"name":"Tiffany Phillips","orcid":null,"position":6,"is_corresponding":false},{"id":451323,"name":"Meeryo Choe","orcid":"0000-0001-8142-9471","position":7,"is_corresponding":false},{"id":247467,"name":"Timothy F. Cloughesy","orcid":"0000-0002-8656-7483","position":8,"is_corresponding":false},{"id":1615007,"name":"Jorge A. Lazareff","orcid":null,"position":9,"is_corresponding":false},{"id":87673,"name":"Linda M. Liau","orcid":"0000-0002-4053-0052","position":10,"is_corresponding":false},{"id":279706,"name":"William H. Yong","orcid":null,"position":11,"is_corresponding":false},{"id":291465,"name":"Thomas G. Graeber","orcid":"0000-0001-8574-9181","position":12,"is_corresponding":false},{"id":297479,"name":"Harley I. Kornblum","orcid":"0000-0002-3779-4540","position":13,"is_corresponding":false},{"id":1534187,"name":"Ming-Fei Lang","orcid":null,"position":14,"is_corresponding":false},{"id":589737,"name":"Yanzhao Li","orcid":"0000-0002-3170-0291","position":15,"is_corresponding":false},{"id":404287,"name":"Jing Sun","orcid":"0000-0002-1223-8986","position":16,"is_corresponding":false},{"id":1614996,"name":"Michael D. Masterman-Smith","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem Cells","abstract":"In glioblastoma, the therapeutically intractable and resistant phenotypes can be derived from glioma stem cells, which often have different underlying mechanisms from non-stem glioma cells. Aberrant signaling across the EGFR-PTEN-AKT-mTOR pathways have been shown as common drivers of glioblastoma. Revealing the inter and intra-cellular heterogeneity within glioma stem cell populations in relations to signaling patterns through these pathways may be key to precision diagnostic and therapeutic targeting of these cells.","is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"39788641","pmcid":null,"openalex_id":"https://openalex.org/W4406135194","authors":[],"funders":[],"total_grants":0,"fwci":1.5143,"citation_percentile":0.79401575,"influential_citations":0,"citation_trend":[{"year":2025,"count":1},{"year":2026,"count":1}],"oa_status":"gold","license":null,"oa_locations":[{"url":"https://www.e-crt.org/upload/pdf/crt-2024-859.pdf","host_type":"journal"},{"url":"https://www.e-crt.org/upload/pdf/crt-2024-859.pdf","host_type":"publisher"},{"url":"http://e-crt.org/upload/pdf/crt-2024-859.pdf","host_type":"publisher"},{"url":"https://doi.org/10.4143/crt.2024.859","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/39788641","host_type":"repository"}],"fields_of_study":["Glioma Diagnosis and Treatment","Cancer Genomics and Diagnostics","Ferroptosis and cancer prognosis"],"mesh_terms":[],"keywords":["PTEN","PI3K/AKT/mTOR pathway","Glioma","Protein kinase B","Cancer research","Phenotype","Stem cell","Medicine","Cancer stem cell","Signal transduction","Biology","Cell biology","Genetics","Gene"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-04T04:36:22.713912Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}